The Agenda

Credit: © Karin Pierre / Institut de Physiologie, Unil, Lausanne" /> Credit: © Karin Pierre / Institut de Physiologie, Unil, Lausanne N IS FOR NEURO » November is neuroscience month, both in our pages (A Potent Protein), and in Washington DC. On the 15th, attendees of the 38th annual meeting of the Society for Neuroscience will gather to hear the latest on their fields. Organizers are expecting more than 30,000 people this yea

Written byThe Scientist
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

N IS FOR NEURO » November is neuroscience month, both in our pages (A Potent Protein), and in Washington DC. On the 15th, attendees of the 38th annual meeting of the Society for Neuroscience will gather to hear the latest on their fields. Organizers are expecting more than 30,000 people this year. For more, visit http://www.sfn.org/am2008.

NOVEL DISORDER » 102 years ago this month, Alois Alzheimer described a patient with trouble with speech and memory. When she died, Alzheimer performed an autopsy, and noticed remarkable changes to the brain. The scientific understanding of Alzheimer's disease has improved, but we are still searching for answers, including from children with related disease Niemann-Pick C, described in "Twin Disorders".

NOTABLE NEWS » Authors Bert Hölldobler and Edward O. Wilson team up once again to pen The Superorganism, a book about social insects such as ants, bees, and wasps. The Pulitzer Prize-winners stage the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies